Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions.
about
Mirtazapine, and mirtazapine-like compounds as possible pharmacotherapy for substance abuse disorders: evidence from the bench and the bedsideGender differences in the effect of tobacco use on brain phosphocreatine levels in methamphetamine-dependent subjectsEffect of add-on valproate on craving in methamphetamine depended patients: A randomized trialPharmacologic Treatment with GABA(B) Receptor Agonist of Methamphetamine-Induced Cognitive Impairment in Mice.Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literatureAdministration of GABA(B) receptor positive allosteric modulators inhibit the expression of previously established methamphetamine-induced conditioned place preference.Estimating the intake of abused methamphetamines using experimenter-administered deuterium labeled R-methamphetamine: selection of the R-methamphetamine dose.Baclofen facilitates the extinction of methamphetamine-induced conditioned place preference in rats.Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.Individual, social, and environmental factors associated with initiating methamphetamine injection: implications for drug use and HIV prevention strategies.The anti-(+)-methamphetamine monoclonal antibody mAb7F9 attenuates acute (+)-methamphetamine effects on intracranial self-stimulation in rats.Repeated mirtazapine nullifies the maintenance of previously established methamphetamine-induced conditioned place preference in rats.Chronic modafinil effects on drug-seeking following methamphetamine self-administration in rats.Attenuation of methamphetamine seeking by the mGluR2/3 agonist LY379268 in rats with histories of restricted and escalated self-administration.Dopamine D(3) receptor antagonist SB-277011A inhibits methamphetamine self-administration and methamphetamine-induced reinstatement of drug-seeking in rats.PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in ratsRivastigmine reduces "Likely to use methamphetamine" in methamphetamine-dependent volunteers.Effect of fendiline on the maintenance and expression of methamphetamine-induced conditioned place preference in Sprague-Dawley rats.Defining the role of baclofen for the treatment of alcohol dependence: a systematic review of the evidence.A brief history of oxytocin and its role in modulating psychostimulant effects.Chronic methamphetamine self-administration disrupts cortical control of cognition.A novel photoaffinity ligand for the dopamine transporter based on pyrovalerone.Brain regions and monoaminergic neurotransmitters that are involved in mouse ambulatory activity promoted by bupropion.Protocol for a systematic review of psychological treatment for methamphetamine use: an analysis of methamphetamine use and mental health symptom outcomes.Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus.Substance abuse is a disease of the human brain: focus on alcohol.The role of reactive oxygen species in methamphetamine self-administration and dopamine release in the nucleus accumbens.Oxytocin in the nucleus accumbens core reduces reinstatement of methamphetamine-seeking behaviour in rats.Identification of Novel Signal Transduction, Immune Function, and Oxidative Stress Genes and Pathways by Topiramate for Treatment of Methamphetamine Dependence Based on Secondary Outcomes.Chronic Methamphetamine Self-Administration Dysregulates Oxytocin Plasma Levels and Oxytocin Receptor Fibre Density in the Nucleus Accumbens Core and Subthalamic Nucleus of the Rat.
P2860
Q24622161-08406C43-8188-4E15-BE21-CA894C3D04C0Q28391911-FCB6D151-7249-44D3-89B5-3A34B1C18438Q28595633-06C6AFF9-E224-46B5-BE74-7FF69EF26CB9Q30474281-B283318C-D0DF-427D-A23A-0FE7DC6F383BQ34181746-78599F08-E44C-45CF-9DEA-98BA45638FECQ34389125-8EF92A76-F4D1-4FAD-817F-2BA2584F128DQ34580744-1B7B16B1-1032-4C30-964C-02C12ABE0A3BQ34794146-F76328B8-7ADE-4754-B5B4-2E30DA63361FQ34982551-47A3650F-36F5-49F3-9CA6-7D07B307A3FBQ35023874-0D0B0DAB-519A-42F9-8E00-D1691FF3FAEEQ35151502-D50BC38D-3526-457B-9CB2-1400D9D06E4EQ35206777-3666E375-6900-4916-BFF3-1D13DF970CBCQ35673212-FCDC8A62-2F1C-468C-AC45-2B0428F55D23Q36233639-BFE42D71-9BC0-4220-A7C8-08C014A37CBAQ37057438-1CA3527E-1EF3-4D5F-99A0-C4D3D8BE96A0Q37060818-63530E21-D6D6-44C0-BE9B-AF66CE84A65AQ37425104-ABBB839C-AB8F-49F8-8E64-F5B2A7D10475Q37705299-1545A923-9D80-4A08-930A-EB9803B34ADDQ37965229-0BF0235F-F38D-47AA-B76B-920279787476Q38076658-F1FEF4D9-8766-49BF-A043-6FA9FC159735Q38906406-FE060099-131B-45C6-89A4-56D758467908Q39851539-DDAE7075-1B2E-4D55-8447-F5FB5FF11032Q41679403-43768B92-9551-42B7-8DE2-25B40B3828ACQ42267653-8DE1FAA3-E75C-4512-8001-E9F95FE23EE6Q42476073-523D0989-7ACD-48F1-BEC0-84FAAB3729FAQ42792814-B8958661-A623-417C-9F7A-2C824A1BB1A0Q46516257-20ED72A2-6E7C-493E-8EF1-678723336883Q48455589-58FE4798-D480-4314-9716-F05FD5028079Q49532909-03EAFF4F-3558-4299-9F37-D4C37ECA07C1Q50549720-C5656E30-5280-449B-ADEE-CE4C5772D804
P2860
Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Pharmacotherapy for methamphet ...... macotherapeutic interventions.
@ast
Pharmacotherapy for methamphet ...... macotherapeutic interventions.
@en
Pharmacotherapy for methamphet ...... macotherapeutic interventions.
@nl
type
label
Pharmacotherapy for methamphet ...... macotherapeutic interventions.
@ast
Pharmacotherapy for methamphet ...... macotherapeutic interventions.
@en
Pharmacotherapy for methamphet ...... macotherapeutic interventions.
@nl
prefLabel
Pharmacotherapy for methamphet ...... macotherapeutic interventions.
@ast
Pharmacotherapy for methamphet ...... macotherapeutic interventions.
@en
Pharmacotherapy for methamphet ...... macotherapeutic interventions.
@nl
P1476
Pharmacotherapy for methamphet ...... macotherapeutic interventions.
@en
P2093
Jon E Grant
Mark E Rose
P304
P356
10.1080/10401230802177656
P577
2008-07-01T00:00:00Z